Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Herb/drug interactions

This article was originally published in The Tan Sheet

Executive Summary

Ginseng and ginkgo biloba inhibit CYP3A4 metabolism in study of 22 healthy individuals between ages 21 and 55, Harbor-University of California at Los Angeles investigators state. Six-phase study explored effect of ginseng, ginkgo and St. John's wort on metabolism of Rx antihypertensive drug nifedipine. Confirming previous reports, St. John's wort was found to have an inducing effect on CYP3A4 1("The Tan Sheet" Feb. 14, 2000, p. 19). HIV-1 protease inhibitors are substrates of the CYP3A4 isozyme. "Caution must be exercised when these herbs are combined with medications that are CYP3A4 substrates," M. Smith, MD, et al., stress. Five other posters presented at ASCPT annual meeting examined drug interactions involving St. John's wort

You may also be interested in...

St. John's Wort/HIV Protease Inhibitor Use Warnings Issued By FDA, NIH

HIV patients taking protease inhibitors should avoid taking St. John's wort dietary supplements, FDA and the National Institutes of Health warned Feb. 10, following the release of study results demonstrating the herbal compromises the antiviral drugs' effectiveness.

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts